28 October 2021

Pharmaceuticals Rheumatoid Arthritis

End of the line for OA drug tanezumab

18 October 2021

Biologics Reactive Arthritis

Rituximab in line for open PBS listing without authority

11 October 2021

COVID-19

ATAGI covid booster recommendations leave rheumatologists with questions

7 October 2021

Biologics Corticosteroids Juvenile Arthritis Spondyloarthritis

Cutting RA meds worth a go: study

16 September 2021

COVID-19

Boost for third covid vax dose

2 September 2021

TGA

ARA calls for changes to b/tsDMARD prescribing

2 September 2021

Gout PBAC

FDA black box blow for all JAK inhibitors

26 August 2021

Public Health Spondyloarthritis

Childhood passive smoking linked with RA

12 August 2021

Rural

Getting started in rural and regional practice

5 August 2021

COVID-19

ACR presents latest real world data on covid vax and rheuma patients

5 August 2021

Pharmacy Guild of Australia Psoriatic Athritis Spondyloarthritis

Tocilizumab shortage: clinical management advice

5 August 2021

Biologics Reactive Arthritis

Anifrolumab breaks lupus green-light drought in the US

29 July 2021

Biologics

ATAGI recommends Shingrix for immunocompromised patients

29 July 2021

Biologics COVID-19 TGA

Covid-19 impacts on people with rheumatic disease: survey

15 July 2021

Conditions COVID-19 Spondyloarthritis

Read the latest magazine!

8 July 2021

Corticosteroids Gastro Gout Rural Spondyloarthritis

Some DMARDs may lower CVD risk in RA patients